1272P Updated Results from a First-in-human, Phase I/II Study of GB263T, a Novel EGFR/cMET/cMET Tri-Specific Antibody, in Patients with Advanced EGFR-mutated (egfrm) Non-Small Cell Lung Cancer (NSCLC)
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined